The percentage of patients who used the device for 70% or more between the active and placebo groups also did not reach statistical significance, with a risk ratio of 1.25 (95% CI 0.74–2.10) and P = 0.40 (as shown in Table 2 ).
← all excerpts
The efficiency of azelastine hydrochloride and fluticasone propionate nasal spray to improve PAP adherence in patients with obstructive sleep apnea.
1
0.4000
0.4000